Ian F Smith Solid Biosciences Inc. (SLDB) insider trading activity

Ian F Smith is of Solid Biosciences Inc.. Currently has a direct ownership of 131,264 shares of SLDB, which is worth approximately $552,621. The most recent transaction as insider was on Jan 06, 2026, when has been sold 4,573 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 131K

3.61% 3M change

16.19% 12M change

Total Value Held $552,621

IAN F SMITH Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 06 2026	BUY Exercise of conversion of derivative security	-	4,573 Added 3.37%	131,264 Common Stock
Oct 06 2025	BUY Exercise of conversion of derivative security	-	4,573 Added 3.48%	126,692 Common Stock
Jul 06 2025	BUY Exercise of conversion of derivative security	-	4,573 Added 3.61%	122,119 Common Stock
Apr 06 2025	BUY Exercise of conversion of derivative security	-	4,574 Added 3.75%	117,546 Common Stock
Jan 03 2025	BUY Exercise of conversion of derivative security	-	3,255 Added 2.8%	112,972 Common Stock
Oct 03 2024	BUY Exercise of conversion of derivative security	-	3,255 Added 2.88%	109,717 Common Stock
Jul 03 2024	BUY Exercise of conversion of derivative security	-	3,255 Added 2.97%	106,462 Common Stock

Apr 03 2024	BUY Exercise of conversion of derivative security	-	3,256 Added 3.06%	103,207 Common Stock
Jan 03 2024	BUY Exercise of conversion of derivative security	-	15,570 Added 13.48%	99,948 Common Stock
Oct 03 2023	BUY Exercise of conversion of derivative security	-	15,569 Added 15.58%	84,378 Common Stock
Jul 03 2023	BUY Exercise of conversion of derivative security	-	15,570 Added 18.45%	68,809 Common Stock
Apr 03 2023	BUY Exercise of conversion of derivative security	-	15,569 Added 22.63%	53,239 Common Stock
Jan 03 2023	BUY Exercise of conversion of derivative security	-	1,620 Added 4.12%	37,670 Common Stock
Dec 02 2022	BUY Grant, award, or other acquisition	-	13,172 Added 3.56%	356,380 Common Stock
Oct 03 2022	BUY Exercise of conversion of derivative security	-	24,312 Added 6.62%	343,208 Common Stock
Jul 03 2022	BUY Exercise of conversion of derivative security	-	24,313 Added 7.08%	318,896 Common Stock
Apr 03 2022	BUY Exercise of conversion of derivative security	-	24,313 Added 7.62%	294,583 Common Stock
Dec 10 2020	BUY Grant, award, or other acquisition	$999,999 $3.7 p/Share	270,270 Added 50.0%	270,270 Common Stock

Also insider at

FHTX

Foghorn Therapeutics Inc. Healthcare

STOK

Stoke Therapeutics, Inc. Healthcare

Chief Executive Officer

IFS

Ian F Smith

Charlestown, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SLDB shares.

Notify only if

Value

Insider Trading

Get notified when an Solid Biosciences Inc. insider buys or sells SLDB shares.

Notify only if

Operation

Value

Type

News

Receive news related to Solid Biosciences Inc.

Track Activities on SLDB

Account